Literature DB >> 16083254

So, you want to look for biomarkers (introduction to the special biomarkers issue).

Joshua LaBaer1.   

Abstract

The burgeoning field of proteomics plays a powerful and relevant role in the discovery of biomarkers, which are biometric measurements that convey information about the biological condition of the subject being tested. Biomarkers have changed the manner in which we diagnose disease, monitor the effect of therapy, classify disease, detect toxicity, and develop new drugs. The central part that proteins command in both disease etiology and treatment make them prime biomarker candidates. Indeed, the majority of clinical tests in use today measure proteins. This perspective introduces the Journal of Proteome Research Special Issue on Proteomics and Biomarkers. It outlines the major applications of biomarkers, discusses the basics of statistically assessing them and considers the crucial choice of sample type. Central considerations of biomarker discovery and validation, particularly with respect to their intended clinical and research applications, are highlighted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083254     DOI: 10.1021/pr0501259

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  18 in total

1.  Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.

Authors:  Si Ai; Jian Zheng; Qing Lin; Rongyan Chen
Journal:  Clin Exp Nephrol       Date:  2012-07-07       Impact factor: 2.801

2.  Mass spectrometry-based proteomics and peptidomics for biomarker discovery in neurodegenerative diseases.

Authors:  Xin Wei; Lingjun Li
Journal:  Int J Clin Exp Pathol       Date:  2008-06-20

Review 3.  Application of proteomic analysis to the study of renal diseases.

Authors:  Matthew P Welberry Smith; Rosamonde E Banks; Steven L Wood; Andrew J P Lewington; Peter J Selby
Journal:  Nat Rev Nephrol       Date:  2009-10-27       Impact factor: 28.314

Review 4.  Proteomic analysis in multiple myeloma research.

Authors:  Jana Cumova; Anna Potacova; Zbynek Zdrahal; Roman Hajek
Journal:  Mol Biotechnol       Date:  2011-01       Impact factor: 2.695

Review 5.  Human body fluid proteome analysis.

Authors:  Shen Hu; Joseph A Loo; David T Wong
Journal:  Proteomics       Date:  2006-12       Impact factor: 3.984

6.  Biomarkers intersect with the exposome.

Authors:  Stephen M Rappaport
Journal:  Biomarkers       Date:  2012-06-07       Impact factor: 2.658

7.  Analysis of Retina and Erythrocyte Glycerophospholipid Alterations in a Rat Model of Type 1 Diabetes.

Authors:  Todd A Lydic; Rebecca Renis; Julia V Busik; Gavin E Reid
Journal:  JALA Charlottesv Va       Date:  2009-12-01

8.  Biomarker discovery in animal health and disease: the application of post-genomic technologies.

Authors:  Rowan E Moore; Jennifer Kirwan; Mary K Doherty; Phillip D Whitfield
Journal:  Biomark Insights       Date:  2007-07-10

9.  Complementary precursor ion and neutral loss scan mode tandem mass spectrometry for the analysis of glycerophosphatidylethanolamine lipids from whole rat retina.

Authors:  Todd A Lydic; Julia V Busik; Walter J Esselman; Gavin E Reid
Journal:  Anal Bioanal Chem       Date:  2009-03-11       Impact factor: 4.142

10.  Autoantibodies in Early Detection of Breast Cancer.

Authors:  Femina Rauf; Karen S Anderson; Joshua LaBaer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-09-29       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.